Copyright Reports & Markets. All rights reserved.

Global Therapeutic Nuclear Medicines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview 1

    • 1.1 Research Scope 1
    • 1.2 Major Manufacturers Covered in This Report 2
    • 1.3 Market Segment by Type 3
      • 1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 4
      • 1.3.2 Radium-223 5
      • 1.3.3 Lutetium-177 6
      • 1.3.4 Iodine-131 6
    • 1.4 Market Segment by Application 7
      • 1.4.1 Global Therapeutic Nuclear Medicines Market Share by Application (2018-2025) 7
      • 1.4.2 Thyroid 8
      • 1.4.3 Bone Metastasis 9
      • 1.4.4 Lymphoma 9
    • 1.5 Study Objectives 10
    • 1.6 Years Considered 10

    2 Global Growth Trends 12

    • 2.1 Global Therapeutic Nuclear Medicines Market Size 12
      • 2.1.1 Global Therapeutic Nuclear Medicines Revenue 2013-2025 12
      • 2.1.2 Global Therapeutic Nuclear Medicines Sales 2013-2025 13
    • 2.2 Therapeutic Nuclear Medicines Growth Rate by Regions 14
      • 2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions 2013-2018 14
      • 2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions 2013-2018 16
    • 2.3 Industry Trends 17
      • 2.3.1 Market Top Trends 17
      • 2.3.2 Market Drivers 18

    3 Market Share by Manufacturers 19

    • 3.1 Therapeutic Nuclear Medicines Sales by Manufacturers 19
      • 3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers 2017-2018 19
      • 3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers 2017-2018 20
    • 3.2 Revenue by Manufacturers 21
      • 3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2018) 21
      • 3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2013-2018) 22
      • 3.2.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio 24
    • 3.3 Therapeutic Nuclear Medicines Price by Manufacturers 24
    • 3.4 Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution and Area Served 25
    • 3.5 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market 26
    • 3.6 Key Manufacturers Therapeutic Nuclear Medicines Product Offered 26
    • 3.7 Mergers & Acquisitions, Expansion Plans 27

    4 Market Size by Type 30

    • 4.1 Sales and Revenue for Each Type 30
      • 4.1.1 Radium-223 Sales and Revenue (2013-2018) 30
      • 4.1.2 Lutetium-177 Sales and Revenue (2013-2018) 30
      • 4.1.3 Iodine-131 Sales and Revenue (2013-2018) 30
    • 4.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type 31
    • 4.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type 33
    • 4.4 Therapeutic Nuclear Medicines Price by Type 35

    5 Market Size by Application 36

    • 5.1 Overview 36
    • 5.2 Global Therapeutic Nuclear Medicines Sales by Application 36

    6 North America 38

    • 6.1 North America Therapeutic Nuclear Medicines Breakdown Data by Company 39
    • 6.2 North America Therapeutic Nuclear Medicines Breakdown Data by Type 40
    • 6.3 North America Therapeutic Nuclear Medicines Breakdown Data by Application 42
    • 6.4 North America Therapeutic Nuclear Medicines Breakdown Data by Countries 43
      • 6.4.1 North America Therapeutic Nuclear Medicines Sales by Countries 43
      • 6.4.2 North America Therapeutic Nuclear Medicines Revenue by Countries 44
      • 6.4.3 United States 46
      • 6.4.4 Canada 46
      • 6.4.5 Mexico 47

    7 Europe 48

    • 7.1 Europe Therapeutic Nuclear Medicines Breakdown Data by Company 49
    • 7.2 Europe Therapeutic Nuclear Medicines Breakdown Data by Type 50
    • 7.3 Europe Therapeutic Nuclear Medicines Breakdown Data by Application 51
    • 7.4 Europe Therapeutic Nuclear Medicines Breakdown Data by Countries 53
      • 7.4.1 Europe Therapeutic Nuclear Medicines Sales by Countries 53
      • 7.4.2 Europe Therapeutic Nuclear Medicines Revenue by Countries 54
      • 7.4.3 Germany 56
      • 7.4.4 France 56
      • 7.4.5 UK 57
      • 7.4.6 Italy 57
      • 7.4.7 Russia 58

    8 Asia Pacific 59

    • 8.1 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Company 60
    • 8.2 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Type 61
    • 8.3 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Application 62
    • 8.4 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Countries 64
      • 8.4.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries 64
      • 8.4.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries 64
      • 8.4.3 China 66
      • 8.4.4 Japan 67
      • 8.4.5 Korea 68
      • 8.4.6 India 69
      • 8.4.7 Southeast Asia 70

    9 Central & South America 71

    • 9.1 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Company 72
    • 9.2 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Type 73
    • 9.3 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Application 74
    • 9.4 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Countries 76
      • 9.4.1 Central & South America Therapeutic Nuclear Medicines Sales by Countries 76
      • 9.4.2 Central & South America Therapeutic Nuclear Medicines Revenue by Countries 77
      • 9.4.3 Brazil 79

    10 Middle East and Africa 80

    • 10.1 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Type 81
    • 10.2 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Application 82
    • 10.3 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Countries 83
      • 10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries 83
      • 10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries 84
      • 10.3.3 Middle East 86
      • 10.3.4 Africa 87

    11 Analysis of Therapeutic Nuclear Medicines Industry Key Manufacturers 88

    • 11.1 Bayer 88
      • 11.1.1 Company Profile 88
      • 11.1.2 Product Information 89
      • 11.1.3 Sales, Price and Revenue 89
    • 11.2 Novartis 90
      • 11.2.1 Company Profile 90
      • 11.2.2 Product Information 91
      • 11.2.3 Sales, Price and Revenue 91
    • 11.3 China Isotope & Radiation 92
      • 11.3.1 Company Profile 92
      • 11.3.2 Product Information 93
      • 11.3.3 Sales, Price and Revenue 93
    • 11.4 Dongcheng 94
      • 11.4.1 Company Profile 94
      • 11.4.2 Product Information 95
      • 11.4.3 Sales, Price and Revenue 95
    • 11.5 Q BioMed 96
      • 11.5.1 Company Profile 96
      • 11.5.2 Product Information 97
      • 11.5.3 Sales, Price and Revenue 97
    • 11.6 Curium Pharmaceuticals 98
      • 11.6.1 Company Profile 98
      • 11.6.2 Product Information 99
      • 11.6.3 Sales, Price and Revenue 99
    • 11.7 Jubilant DraxImage 100
      • 11.7.1 Company Profile 100
      • 11.7.2 Product Information 101
      • 11.7.3 Sales, Price and Revenue 101
    • 11.8 Lantheus 102
      • 11.8.1 Company Profile 102
      • 11.8.2 Product Information 103
      • 11.8.3 Sales, Price and Revenue 103
    • 11.9 Spectrum Pharmaceuticals 104
      • 11.9.1 Company Profile 104
      • 11.9.2 Product Information 105
      • 11.9.3 Sales, Price and Revenue 105
    • 11.10 Progenics Pharmaceuticals 106
      • 11.10.1 Company Profile 106
      • 11.10.2 Product Information 107
      • 11.10.3 Sales, Price and Revenue 107
    • 11.11 International Isotopes 108
      • 11.11.1 Company Profile 108
      • 11.11.2 Product Information 109
      • 11.11.3 Sales, Price and Revenue 109

    12 Value Chain and Sales Channels Analysis 111

    • 12.1 Value Chain Analysis 111
    • 12.2 Sales Channels Analysis 112
      • 12.2.1 Therapeutic Nuclear Medicines Sales Channels 112
      • 12.2.2 Therapeutic Nuclear Medicines Distributors 114
    • 12.3 Therapeutic Nuclear Medicines Customers 116

    13 Market Forecast 118

    • 13.1 Global Therapeutic Nuclear Medicines Sales and Revenue Forecast 2019-2025 118
    • 13.2 Global Therapeutic Nuclear Medicines Sales Forecast by Type 119
    • 13.3 Global Therapeutic Nuclear Medicines Sales Forecast by Application 121
    • 13.4 Therapeutic Nuclear Medicines Forecast by Regions 122
      • 13.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions2019-2025 122
      • 13.4.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions2019-2025 123
    • 13.5 North America Market Forecast 124
      • 13.5.1 North America Therapeutic Nuclear Medicines Forecast by Countries 2019-2025 124
      • 13.5.2 United States 125
      • 13.5.3 Canada 126
      • 13.5.4 Mexico 126
    • 13.6 Europe Market Forecast 127
      • 13.6.1 Europe Therapeutic Nuclear Medicines Forecast by Countries 2019-2025 127
      • 13.6.2 Germany 128
      • 13.6.3 France 129
      • 13.6.4 UK 129
      • 13.6.5 Italy 130
      • 13.6.6 Russia 130
    • 13.7 Asia Pacific Market Forecast 131
      • 13.7.1 Asia Pacific Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025 131
      • 13.7.2 China 132
      • 13.7.3 Japan 133
      • 13.7.4 Korea 133
      • 13.7.5 India 134
      • 13.7.6 Southeast Asia 134
    • 13.8 Central & South America Market Forecast 135
      • 13.8.1 Central & South America Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025 135
      • 13.8.2 Brazil 136
    • 13.9 Middle East and Africa Market Forecast 137
      • 13.9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025 137
      • 13.9.2 Middle East 138
      • 13.9.3 Africa 139

    14 Research Findings and Conclusion 140

      15 Appendix 141

      • 15.1 Research Methodology 141
        • 15.1.1 Methodology/Research Approach 141
        • 15.1.2 Data Source 145
      • 15.2 Author Details 147
      • 15.3 Disclaimer 148

      In the last several years, global market of Therapeutic Nuclear Medicines developed rapidly, with an average growth rate of 22.9%. In 2018, global revenue of Therapeutic Nuclear Medicines is nearly 855 M USD; the actual production is about 1000 thousand units.

      This study researches the market size of Therapeutic Nuclear Medicines, presents the global Therapeutic Nuclear Medicines sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2019, and forecast to 2025.

      This report focuses on the key data information of Therapeutic Nuclear Medicines in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Therapeutic Nuclear Medicines for each region and countries in each region.

      For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2017 to 2018.

      This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors analysis.

      This report includes the following manufacturers: (we can also add the other companies as you want)
      Bayer
      Novartis AG
      China Isotope & Radiation
      Dongcheng
      Q BioMed
      Curium Pharmaceuticals
      Jubilant DraxImage
      Lantheus
      Spectrum Pharmaceuticals
      Progenics Pharmaceuticals
      International Isotopes

      Market Segment by Product Type
      Radium-223
      Lutetium-177
      Iodine-131
      Other

      Market Segment by Application
      Thyroid
      Bone Metastasis
      Lymphoma
      Other

      Key Regions split in this report:
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Southeast Asia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Rest of Europe
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      Middle East
      Africa

      Buy now